Vactech

Vactech Logo blue

Vactech is pioneering the future of immunology through the development of innovative vaccines and diagnostic technologies targeting type 1 diabetes (T1D), celiac disease, and enterovirus-related conditions. Since our foundation, our mission has been clear: to advance research with real-world impact, combining academic excellence with strong commercial potential and strategic industrial partnerships. Our flagship innovation—a patented preventive vaccine for T1D—is currently progressing in clinical development.

Role in the project

Beneficiary. Leading WP5 – Distinction of immune responses induced by CVB infections vs vaccination.

Principal investigators

TeroValimaa
Tero Välimaa